Main Page: Difference between revisions

From Protocopedia
Jump to navigation Jump to search
VisualWikitext
 
(30 intermediate revisions by the same user not shown)
Line 10: Line 10:
! Section !! Description !! Revision Date !! Reviewed Date
! Section !! Description !! Revision Date !! Reviewed Date
|-
|-
| 1.01 || [[General Measures]] || February-18 ||
| 1.01 || [[General Measures]] || March-24 ||March-24
|-
|-
| 1.02 || [[Radio Report Format]] || July-21 ||
| 1.02 || [[Radio Report Format]] || July-21 ||
Line 52: Line 52:
| 1.21|| [[Freestanding ED Transport Criteria]]|| April-23 ||
| 1.21|| [[Freestanding ED Transport Criteria]]|| April-23 ||
|-
|-
| 1.22|| [[Hospital Capability Chart - DRAFT|Hospital Capability Chart]]|| September-23 ||September-23
| 1.22|| [[Hospital Capability Chart - DRAFT|Hospital Capability Chart]]|| May-24 ||May-24
|-
|-
| 1.23|| [[Documentation Guidance]]|| June-17 ||
| 1.23|| [[Documentation Guidance]]|| June-24 ||June-24
|-
|-
| 1.24|| [[School Medication Authorization Forms]]|| June-18 ||
| 1.24|| [[School Medication Authorization Forms]]|| June-18 ||
|}
|}


Line 86: Line 87:
| 3.02|| [[Carbon Monoxide Inhalation]]|| June-19
| 3.02|| [[Carbon Monoxide Inhalation]]|| June-19
|-
|-
| 3.03|| [[Foreign Body Airway Obstruction]]|| March-09
| 3.03|| [[Foreign Body Airway Obstruction]]|| October-24
|-
|-
| 3.04|| [[Infectious Upper Airway Obstruction - Croup or Epiglottitis]]|| April-16
| 3.04|| [[Infectious Upper Airway Obstruction - Croup or Epiglottitis]]|| April-16
Line 105: Line 106:
|4.02 || [[Asystole]]||December-22
|4.02 || [[Asystole]]||December-22
|-
|-
|4.03 || [[Atrial Fibrillation Atrial Flutter]]||June-17
|4.03 || [[Atrial Fibrillation Atrial Flutter]]||April-20
|-
|-
|4.04||[[Pulseless Electrical Activity (PEA)]]||January-16
|4.04||[[Pulseless Electrical Activity (PEA)]]||January-16
Line 111: Line 112:
|4.05||[[Premature Ventricular Contractions (PVC)]]||May-12
|4.05||[[Premature Ventricular Contractions (PVC)]]||May-12
|-
|-
|4.06||[[Supraventricular Bradycardia and AV Blocks]]||March-09
|4.06||[[Supraventricular Bradycardia and AV Blocks]]||April-24
|-
|-
|4.07||[[Supraventricular Tachycardia]]||January-20
|4.07||[[Supraventricular Tachycardia]]||January-20
Line 142: Line 143:
|5.03||[[Altered Mental Status (AMS)]]||April-17
|5.03||[[Altered Mental Status (AMS)]]||April-17
|-
|-
|5.04||[[Suspected Stroke Transcient Ischemic Attack TIA|Suspected Stroke or Transcient Ischemic Attack]]||April-23
|5.04||[[Suspected Stroke Transcient Ischemic Attack TIA|Suspected Stroke or Transcient Ischemic Attack]]||May-24
|-
|-
|5.05||[[Drug Overdose Poisoning]]||March-09
|5.05||[[Drug Overdose Poisoning]]||March-09
Line 168: Line 169:
|5.16||[[Vertigo]]||March-09
|5.16||[[Vertigo]]||March-09
|-
|-
|5.17||[[Sepsis Septic Shock]]||May-19
|5.17||[[Sepsis Septic Shock]]||Jan-24
|-
|-
|5.18||[[Suspected Kidney Stone]]||April-16
|5.18||[[Suspected Kidney Stone]]||April-16
Line 179: Line 180:
|-
|-
|5.22||[[Acute Adrenal Insufficiency]]||June-18
|5.22||[[Acute Adrenal Insufficiency]]||June-18
|-
|5.23
|[[CORE Opioid Addiction Recovery]]
|October-24
|}
|}


Line 197: Line 202:
|6.05||[[Decompression Sickness or Dysbarism]]||March-09
|6.05||[[Decompression Sickness or Dysbarism]]||March-09
|-
|-
|6.06||[[Extremity Injuries]]||February-15
|6.06||[[Extremity Injuries]]||January-24
|-
|-
|6.07||[[Head Injuries]]||November-21
|6.07||[[Head Injuries]]||September-24
|-
|-
|6.08||[[Near Drowning]]||March-09
|6.08||[[Near Drowning]]||March-09
Line 209: Line 214:
|6.11||[[Suspected Sexual Assault]]||March-09
|6.11||[[Suspected Sexual Assault]]||March-09
|-
|-
|6.12||[[Trunk Penetrating Injuries]]||April-12
|6.12||[[Trunk Penetrating Injuries]]||January-24
|-
|-
|6.13||[[Hemorrhagic Shock]]||October-18
|6.13||[[Hemorrhagic Shock]]||October-18
Line 266: Line 271:
|-
|-
|[[Amiodarone]]||July-17
|[[Amiodarone]]||July-17
|-
|[[Ancef]]||January-24
|-
|-
|[[Aspirin]]||March-09
|[[Aspirin]]||March-09
Line 294: Line 301:
|-
|-
|[[Glucagon]]||April-16
|[[Glucagon]]||April-16
|-
|[[Hypertonic Saline|Hypertonic (3%) Saline]]||September-24
|-
|[[Keppra]]||September-24
|-
|-
|[[Ketamine]]||November-20
|[[Ketamine]]||November-20
Line 329: Line 340:
|[[Solu-Medrol]]||January-17
|[[Solu-Medrol]]||January-17
|-
|-
|[[Toradol]]||March-09
|[[Toradol]]||August-24
|-
|-
|[[TXA]]||October-20
|[[TXA]]||October-20
Line 430: Line 441:
|9.38||[[iTClamp Hemorrhage Control System]]||Feb-15
|9.38||[[iTClamp Hemorrhage Control System]]||Feb-15
|-
|-
|9.39||[[I-gel Supraglottic Airway]]||May-16
|9.39||[[I-gel Supraglottic Airway]]||February-24
|-
|-
|9.40||[[T-POD Pelvic Stabilization Device]]||Sept-23
|9.40||[[T-POD Pelvic Stabilization Device]]||Sept-23
|-
|9.41||[[Controlled Substance Disposal Procedures]]||Mar-24
|-
|9.42||[[LifeVac]]||Oct-24
|}
|}


Latest revision as of 19:51, 22 October 2024

TABLE OF CONTENTS

Medical Director Authorization

Section 1 - Administrative Policies

Section Description Revision Date Reviewed Date
1.01 General Measures March-24 March-24
1.02 Radio Report Format July-21
1.03 Refusal of Service October-17
1.04 Physician or Nurse on Scene March-09
1.05 Initiation of CPR and Determination of Death July-16
1.06 Determination of Death in Trauma March-09
1.07 Crime or Unattended Death Scene March-09
1.08 Medical Evaluation of Person in Police Custody March-09
1.09 Trauma Transport Protocol February-19
1.10 Emergency Transport March-09
1.11 Criteria for Helicopter Transport March-09
1.12 Medical Patient Transport Decision April-14
1.13 Obstetrical Patient Transport Decision October-20
1.14 Emergency Inter Facility Transport March-09
1.15 EMS Saturation Disaster Response Levels April-16
1.16 EMS Offload Policy March-09
1.17 EMT and Paramedic County Certification Procedure July-23
1.18 EMS Quality Improvement Program March-09
1.19 Post Exposure Prophylaxis (PEP) November-21
1.20 Scope of Practice July-23
1.21 Freestanding ED Transport Criteria April-23
1.22 Hospital Capability Chart May-24 May-24
1.23 Documentation Guidance June-24 June-24
1.24 School Medication Authorization Forms June-18

Section 2 - Primary Care

Section Description Revision Date
2.01 Initial Medical Assessment and Care March-09
2.02 Initial Trauma Assessment and Care September-17
2.03 Rapid Trauma Assessment, Focused History and Physical Exam Sept-15
2.04 Analgesia and Sedation December-20
2.05 Drug Assisted Intubation December-16

Section 3 - Respiratory

Section Description Revision Date
3.01 Acute Asthma or COPD with Wheezing February-19
3.02 Carbon Monoxide Inhalation June-19
3.03 Foreign Body Airway Obstruction October-24
3.04 Infectious Upper Airway Obstruction - Croup or Epiglottitis April-16
3.05 Severe Respiratory Pathogens November-10
3.06 Anxiety or Hyperventilation February-11

Section 4 - Cardiac

Section Description Revision Date
4.01 Chest Pain Acute Coronary Syndrome Mar-22
4.02 Asystole December-22
4.03 Atrial Fibrillation Atrial Flutter April-20
4.04 Pulseless Electrical Activity (PEA) January-16
4.05 Premature Ventricular Contractions (PVC) May-12
4.06 Supraventricular Bradycardia and AV Blocks April-24
4.07 Supraventricular Tachycardia January-20
4.08 Ventricular Fibrillation Pulseless Ventricular Tachycardia December-16
4.09 Ventricular Tachycardia with a Palpable Pulse July-12
4.10 Wide Complex Tachycardia Uncertain Origin January-20
4.11 Acute Cardiogenic Pulmonary Edema Pneumonia March-09
4.12 Code Cool Post ROSC Induced Hypothermia March-09
4.13 Adult Immediate Post-Cardiac Arrest Care April-12
4.14 Ventricular Assist Devices March-22

Section 5 - Medical

Section Description Revision Date
5.01 Acute Abdominal Pain April-16
5.02 Allergic Reaction Anaphylactic Shock March-19
5.03 Altered Mental Status (AMS) April-17
5.04 Suspected Stroke or Transcient Ischemic Attack May-24
5.05 Drug Overdose Poisoning March-09
5.06 Cold Emergencies April-12
5.07 Heat Emergencies August-15
5.08 Hazardous Materials July-22
5.09 Severe Hypertension March-09
5.10 Hypo or Hyperglycemia April-16
5.11 Psychological Behavioral Emergencies March-09
5.12 Seizure April-16
5.13 Non-Hemorrhagic Shock October-18
5.14 Sickle Cell Anemia Crisis March-09
5.15 Syncope March-09
5.16 Vertigo March-09
5.17 Sepsis Septic Shock Jan-24
5.18 Suspected Kidney Stone April-16
5.19 Cyanide Poisoning April-16
5.20 Excited Delirium or Drug Induced Agitation November-17
5.21 Ebola Virus Disease Patient Management October-14
5.22 Acute Adrenal Insufficiency June-18
5.23 CORE Opioid Addiction Recovery October-24

Section 6 - Trauma

Section Description Revision Date
6.01 Animal Bites Stings August-18
6.02 Burns - Thermal, Electrical, Chemical March-09
6.03 Selective Spinal Immobilization August-14
6.04 Chest Injuries March-09
6.05 Decompression Sickness or Dysbarism March-09
6.06 Extremity Injuries January-24
6.07 Head Injuries September-24
6.08 Near Drowning March-09
6.09 Ophthalmic Injuries March-09
6.10 Suspected Abuse Neglect March-09
6.11 Suspected Sexual Assault March-09
6.12 Trunk Penetrating Injuries January-24
6.13 Hemorrhagic Shock October-18

Section 7 - Pediatric and Obstetrical

Section Description Revision Date
7.01 Pediatric Asystole April-16
7.02 Pediatric Pulseless Electrical Activity PEA April-16
7.03 Pediatric Ventricular Fibrillation or Pulseless Ventricular Tachycardia April-16
7.04 Pregnancy Induced Hypertension (PIH) April-20
7.05 Preterm Labor November-17
7.06 Emergency Childbirth November-17
7.07 Childbirth Complications November-17
7.08 Newborn Care April-16
7.09 Post Partum Care November-17
7.10 Pediatric Febrile Emergency April-16
7.11 Vaginal Bleeding March-09
7.12 Trauma In Pregnancy March-09

Section 8 - Medication Guidelines

INTRODUCTION The following pages contain guidelines for the medications commonly encountered by the Paramedic. They identify the name and class of the drug, a short description, indications, contraindications, precautions, and dosages. This is only a guideline to medication administration and shall not circumvent the need to refer to the appropriate Standing Order or to contact Medical Control for orders and consultation. For detailed and extensive information on each drug, refer to the Physician's Desk Reference, the Advanced Cardiac Life Support text or an emergency pre-hospital pharmacology reference.

Certain medications listed have various dosages depending on the patient's condition. Refer to the appropriate Standing Order or contact Medical Control for specific dosage information. All IV piggyback medications must be placed on a micro-gtt. solution set for field administration and if available, an infusion pump or infusion regulator MUST BE UTILIZED.

The following medications are authorized to be administered by Seminole County EMS:

Medication Name Revision Date
Acetaminophen March-09
Adenosine January-20
Albuterol April-16
Amiodarone July-17
Ancef January-24
Aspirin March-09
Atropine July-17
Atrovent April-16
Calcium Chloride April-16
Cardizem July-17
Cyanokit April-16
Dextrose 10% April-16
Dextrose 50% April-16
Diphenhydramine April-16
Dopamine April-16
Epinephrine April-16
Flumazenil April-16
Geodon April-16
Glucagon April-16
Hypertonic (3%) Saline September-24
Keppra September-24
Ketamine November-20
Lasix April-16
Lidocaine July-17
Magnesium Sulfate April-16
Morphine Sulfate November-16
Naloxone April-16
Nitro Drip April-17
Nitro Spray April-17
Nitro Tablets April-17
Nitrous Oxide November-16
Oxygen March-09
Pepcid April-16
Pontocaine November-17
Promethazine April-16
Racemic Epinephrine April-16
Sodium Bicarbonate April-16
Solu-Medrol January-17
Toradol August-24
TXA October-20
Xopenex April-16
Valium April-16
Versed April-16
Zofran April-16
Medication Infusion Tables March-09

Section 9 - Procedure Guidelines

Section Description Revision Date
9.00 Lucas Device November-21
9.01 Autovent March-09
9.02 Blood Alcohol Draw on Scene March-18
9.03 Blood Draw using Vacutainer Tubes March-09
9.04 Blood Glucose Test March-09
9.05 Buretrol Usage March-09
9.06 Cardiac Monitor April-12
9.07 Cardioversion March-09
9.08 Continuous Positive Airway Pressure Device March-09
9.09 Cricothyrotomy Needle March-09
9.10 Cricothyrotomy Surgical March-09
9.11 Defibrillation March-09
9.12 Defibrillation Pediatric March-09
9.13 End Tidal CO2 Monitoring and Capnography March-09
9.14.1 Intraosseous Infusion - Femoral February-15
9.14.2 Intraosseous Infusion - Humeral Head December-16
9.15 Intubation Endotracheal March-09
9.16 Intubation Nasotracheal March-09
9.17 IVAC Medsystem III MultiChannel Infusion Pump March-09
9.18 King Tube March-09
9.19 Medication Administration Intramuscular March-09
9.20 Medication Administration Nasal Atomizer March-09
9.21 Medication Administration Nebulizer March-09
9.22 Medication Administration Subcutaneous March-09
9.23 Nasogastric/Orogastric Tube March-09
9.24 Oxygen Administration March-09
9.25 Peripheral IV Administration March-09
9.26 Pleural Decompression March-09
9.27 Removal of Taser Probes March-09
9.28 Reconstitution of Medications March-09
9.29 ResQPOD Impedance Threshold Device March-09
9.30 Transcutaneous Pacing Procedure March-09
9.31 ResQGuard Impedance Threshold Device April-11
9.32 Emergency Chest Wall Escharotomy April-11
9.33 Venous Lactate Monitoring Procedure May-12
9.34 Central Venous Access Devices June-12
9.35 Medication Administration Cross Check Jun-12
9.36 Combat Application Tourniquet Jan-14
9.37 Zoll LifeVest Wearable Defibrillator Dec-14
9.38 iTClamp Hemorrhage Control System Feb-15
9.39 I-gel Supraglottic Airway February-24
9.40 T-POD Pelvic Stabilization Device Sept-23
9.41 Controlled Substance Disposal Procedures Mar-24
9.42 LifeVac Oct-24

Section 10 - References

Section Description Revision Date
10.01 Abbreviations March-09
10.02 Apgar Score March-09
10.03 Glasgow Coma Score March-09
10.04 Pediatric Vital Signs March-09
10.05 Adult Trauma Alert Criteria March-09
10.06 Pediatric Trauma Alert Criteria March-09
10.07 Pediatric Trauma Score March-09
10.08 Nitroglycerin Drip March-09
10.09 Checking Range of Motion March-09
10.10 Rule of Nines March-09
10.11 Florida Statutes March-09
10.12 Evaluation and Treatment Flow Chart March-09
10.13 Spinal Injury Assessment Critical Criteria March-09
10.14 Celox Gauze Powerpoint April-12
10.15 Sepsis and Venous Lactate Powerpoint April-12
10.16 LVAD EMS Guide Sept-18
10.16.1 HeartMate III LVAD - Green Sept-18
10.16.2 HeartMate II LVAD - Red Sept-18
10.16.3 HeartWare LVAD - Dark Blue Sept-18
10.16.4 Jarvik 2000 LVAD - Lavendar Sept-18
10.16.5 Thoratec LVAD - Light Blue Sept-18
10.16.6 DuraHeart LVAD - Purple Sept-18
10.16.7 Total Artificial Heart LVAD - Pink Sept-18

Section 11 - Medical Director Memos

Subject Effective Date
Memo - Hurricane Ian – EMS OPERATIONS 2022-09-28
Memo - Masks Required in ED's 2022-08-22
Memo - QA/QI Program 2022-03-21
Memo - Additional EMS Skills 2020-09-01
Memo - Transport of SEPSIS Patients to Freestanding ED's 2020-07-15
Clarification on Destination Choices 2019-11-14
Transport to the OD Hospital – Advent Health Altamonte Clarification 2019-11-07
Transport to the OD Hospital – Advent Health Altamonte 2019-11-04
Further clarification on Advent Health OD Facility 2019-08-26
Transporting of Overdose Patients to AdventHealth Altamonte 2019-08-12
EMS Reports on Lift Assists 2019-03-01
Blood Draws - Nurses refusing tubes 2018-08-23
Clarification of Baker Act patients transported by EMS 2018-04-11
Opening of Oviedo Medical Center 2017-01-29
Blood Draws - Florida Hospital 2017-01-25
Medical Alerts 2016-04-27
Florida Hospital East Pediatric ED 2015-11-23
Discontinuation of Central Venous Access 2013-08-03
Shortage of Atropine 2013-04-11
EMS Blood Draws for SSCH 2013-03-07
Respiratory/Breathing Treatments 2012-12-19
OB Transports 2011-01-14
Aspirin Administration Documentation 2010-12-01
Transport of Psychiatric Patients 2010-05-17
Alert Terminology 2010-05-06
Transport of STEMI Patients 2010-03-19
Aircare Update 2010-03-19
Delayed Offloads with Critical or Unstable Patients 2010-02-25
Transport of STEMI Patients 2010-02-19
Response to Physicians Offices 2009-10-14
Patient Reports Being Given to Hospitals 2009-09-23
Patient Medications 2009-07-20
H1N1 Update 2009-06-24
Multiple Patient Refusal - Wording 2009-06-04
Request for Call Reviews 2009-05-14
H1N1 Update 2009-05-05
Clarification on Selection for Spinal Immobilization 2009-04-30
EKG Strips 2009-04-23
Patient Medications 2009-04-23
Leaving run reports at the E.R. 2009-02-03
Hyperbaric Chamber at CFRH 2008-10-16
Stemi Transport Destinations 2008-07-22
STEMI Alerts to Winter Park Hospital 2008-02-04
Documentation of Medications 2005-01-27

Section 12 - Paramedic Clinical Assessment Program

Section Description Revision Date
12.01 PCAP Guidelines Jan-19
12.02 ALS Contact Form June-10
12.03 Evaluation Form - Equip Jan-13
12.04 Evaluation Form - Protocols Jan-13
12.05 ALS Contact Definition June-10
12.06 Daily Performance Eval Sept-17
12.07 MD Meetings Roster May-13
12.08 Mentor Evaluation May-13
12.09 Verification of EMT Skills May-13
12.10 PCAP Completion Checklist Sept-17
12.11 Verification of Paramedic Skills May-13
12.12 ALS Contact Form Example 1 Dec-14
12.13 ALS Contact Form Example 2 Dec-14
12.14 Incapacitated Patient Management Dec-14

Section 13 - COVID-19

Section Description Revision Date
13.01 MD Memo - Please use Common Sense 2020-03-13
13.02 Hospital Screening and Procedures 2020-03-26
13.03 Dispatch Screening and Procedures 2020-04-01
13.04 Strict Respiratory Precautions Question Card 2020-04-01
13.05 American Red Cross Changed Response Procedures 2020-03-31
13.06 Clearance of COVID Positive, symptomatic and or exposed individuals from our previous advice 2020-07-15
13.07 Updated COVID Transport to FSED 2020-07-20


Link to MD Meeting Sign In

Retrieved from "http://roaddoc.com/scems/index.php?title=Main_Page&oldid=1780"